NCT05206773: An ongoing trial by Sanofi
This trial is ongoing. It must report results 5 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05206773 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled, 12-month Phase 3 Study to Evaluate the Effect of Venglustat on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Who Are Treatment-naïve or Untreated for at Least 6 Months |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 11, 2022 |
| Completion date | Dec. 17, 2025 |
| Required reporting date | Dec. 17, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 19, 2026 |
| Days late | None |